Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma in Vivo With Susceptibility Contrast MRI

Cancer Research - United States
doi 10.1158/0008-5472.can-17-0248
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sphingosine Kinase 1 Overexpression Contributes to Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

OncoImmunology
OncologyAllergyImmunology
2018English

Association of Angiopoietin-2 and Ki-67 Expression With Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2016English

Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2013English

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology
Oncology
2010English

Mapping Hypoxia in Renal Carcinoma With Oxygen-Enhanced MRI: Comparison With Intrinsic Susceptibility MRI and Pathology

Radiology
Nuclear MedicineRadiologyImaging
2018English

In Vitro and in Vivo Evaluation of Targeted Sunitinib-Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma

Journal of Ultrasound in Medicine
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingMedicine
2016English

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy

New England Journal of Medicine
Medicine
2016English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy